Neuronetics, Inc.

📍 Malvern, United States👥 219 employees💰 Last funded Jan 2022
Neuronetics, Inc., is the creator of NeuroStar Advanced Therapy, the market leader in Transcranial Magnetic Stimulation (TMS) for the treatment of Major Depressive Disorder and other mental health conditions. Based in Malvern, PA, we are a public medical device company (STIM) with a strategic vision of transforming the lives of patients whenever and wherever they need it with the best neurohealth therapies in the world. NeuroStar is the #1 TMS choice of doctors, with over 6.4 million treatments performed to date. It is an advanced treatment for depression and other mental health conditions. It is not medication, shock therapy, or surgery. NeuroStar is an outpatient treatment done in as little as 20 minutes for 36 sessions. It promotes neuroplasticity to target mental health where it starts — the brain. Neuronetics markets NeuroStar Advanced Therapy throughout the United States and select markets around the world. If you have questions or comments about NeuroStar, please e-mail us at customersupport@neurostar.com. For U.S. phone support, please call us at (877) 600-7555, for international customers, our number is +1 (610) 640-4207. Please visit NeuroStar.com/Safety for full safety and prescribing information.
2
Total investors
0
Early stage
0
Mid stage
0
Late stage
Founded
Investor geography1 country
United States
2
Frequently asked questions
Who invested in Neuronetics, Inc.?
Neuronetics, Inc. has 2 investors on record on gritt.io.
When did Neuronetics, Inc. last raise funding?
The most recent investment in Neuronetics, Inc. recorded on gritt.io was in January 2022.
What industry is Neuronetics, Inc. in?
Neuronetics, Inc. operates in Medical Equipment Manufacturing. Find similar Medical Equipment Manufacturing investors on gritt.io.
Where is Neuronetics, Inc. based?
Neuronetics, Inc. is headquartered in Malvern, United States.